investordatabase.org

LongeVC

longevc.com Direct investor

LongeVC is a venture capital firm that invests in early-stage biotech and longevity companies. Its stated focus areas are therapeutics, diagnostics and prevention, and longevity infrastructure.

LongeVC is a venture capital firm headquartered in Washington D.C., United States. It invests directly in companies, at seed, in biotech, longevity, therapeutics and diagnostics.

“LongeVC is a venture capital firm investing in an ageless future. Through supporting exceptional early stage founders, our mission is to bring breakthrough biotech to market”

— LongeVC, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed
Headquarters
Washington D.C., United States
Sectors
biotech, longevity, therapeutics, diagnostics, prevention, longevity infrastructure

Team, as LongeVC publishes it

  • Garri Zmudze Managing Partner
  • Ilya Suharenko Managing Partner
  • Sergey Jakimov Managing Partner
  • Vlad Cernoutan Principal
  • Artem Trotsyuk Operating Partner - US
  • Tom Sturitis Chief Operational Officer
  • Konstantinos Maitos Chief Financial Officer
  • Artemy Shumskiy Principal
  • James Bogenberger Therapeutics Team Lead
  • Greg Fishman Venture Partner
  • Matthew Toner Venture Partner

Names and roles exactly as listed on longevc.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page LongeVC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 14158 · added 2026-10-20 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under